Stock A2FY34 AFYA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Afya Limited Sao Paulo

Equities

A2FY34

BRA2FYBDR000

Market Closed - Sao Paulo
Other stock markets
 09:53:27 2024-07-01 am EDT 		5-day change 1st Jan Change
48.11 BRL -2.41% Intraday chart for Afya Limited -2.41% -9.40%
Jul. 02 Afya Closes $116.7 Million Acquisition of Unidom Participacoes MT
Jul. 01 Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors CI

Evolution of the average Target Price on Afya Limited

Price target over the last 5 years

History of analyst recommendation changes

89113551df0bbbbfa1.0YT4ny_2AdqQK0IY_IrOWUwkwtFays36v3WqwJE_RRo.lfe392SvNvfkBhJ5pN_3NSJ2q6EbiLXJhgabks50FCi7sLbGGI9bicpRBw~ed04c67e73bbfacc430236cc21480c92

Analyst Recommendations on Afya Limited

Morgan Stanley Adjusts Price Target on Afya to $19 From $21, Maintains Equalweight Rating MT
JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22 MT
Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating MT
UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating MT
Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18 MT
UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating MT
Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating MT
Afya : Sustainalytics ESG Risk Rating Is Publicly Available BU
Afya : Sustainalytics ESG Risk Rating is Publicly Available PU
AFYA : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32 MT
AFYA : UBS Upgrades Afya to Buy From Neutral, Citing Recent Sell-Off, Resiliency, Cash Generation; Price Target to $27 From $29.50 MT
AFYA : JPMorgan Upgrades Afya to Overweight From Neutral; Price Target is $34 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
93.03 BRL
Average target price
120.6 BRL
Spread / Average Target
+29.68%
High Price Target
134.5 BRL
Spread / Highest target
+44.53%
Low Price Target
103.7 BRL
Spread / Lowest Target
+11.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Afya Limited

Morgan Stanley
JPMorgan Chase
Credit Suisse
UBS
Goldman Sachs
J.P. Morgan Chase

Ratings for Afya Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AFYA Stock
  4. A2FY34 Stock
  5. Consensus Afya Limited